View Single Post
Old 09-01-2018, 09:47 PM
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
Default Project Update - June 11, 2018

The Melbourne, Australia project keeps rolling on:
- All 4 patients in the first cohort have received their 30 million stem cells.
- All 4 patients in the second cohort have received their 50 million stem cells.
- The first patient in the third cohort has received his/her 70 million stem cells.

"The study will conclude following the dosing of the last three patients of the third cohort, which ISCO plans to complete in 2018."

"... we continue to see encouraging signs of improvement that are dose-dependent, with patients with higher dosage performing better on average than patients with lower dosage ..."

Press Releases: International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical Trial
jeffreyn is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
anagirl (09-02-2018)